{"ticker": {"uuid": "299b8d3c-6a0d-4798-8b63-96b7d1aef76d", "symbol": "ELV", "name": "Elevance Health Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Healthcare Plans"}, "articles": [{"title": "Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/elevance-health-elv-beats-q2-032418395.html", "source_name": "Simply Wall St.", "published_at": "2026-07-16T03:24:18+00:00", "published_display": "16 Jul 2026 03:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Q2 2026 Earnings Call Transcript", "summary": "", "url": "https://finance.yahoo.com/m/8f94590a-3346-3440-9309-ff8df1743e88/elevance-health-%28elv%29-q2-2026.html", "source_name": "Motley Fool", "published_at": "2026-07-16T00:32:19+00:00", "published_display": "16 Jul 2026 00:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analyst Report: Elevance Health, Inc.", "summary": "", "url": "https://finance.yahoo.com/m/76a9d924-2686-32d9-b300-fad96b24e8e7/analyst-report%3A-elevance.html", "source_name": "Morningstar Research", "published_at": "2026-07-16T00:12:27+00:00", "published_display": "16 Jul 2026 00:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Q2 2025 earnings summary", "summary": "Elevance Health reported Q2 2025 operating revenue of $49.4 billion, a 14.3% year-over-year increase, driven by higher premium yields and Medicare Advantage growth, but net income decreased by 24.2% to $1.74 billion due to elevated medical costs. The company revised its full-year", "url": "https://quartr.com/events/elevance-health-inc-elv-q2-2025_3e3sT0pc", "source_name": "Quartr", "published_at": "2026-07-16T00:08:00", "published_display": "16 Jul 2026 00:08", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Nears Earnings With Long Term Confidence Testing A Fair Value View", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T21:35:58+00:00", "published_display": "15 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Inc (ELV) Stock Down 8.5% -- Now Undervalued? GF Score: 88/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZDFqNDY4aFhqTnRSM3AtLWZuMTA1S2JTUllMWDlnME80djRUZGMtSWlNTjFNcGpvbDg0SW9Fci1jTDlIN015Q3hFWFZSODNqOVE2YWQ4N1d2UzhWaEhCSl9xVlpNYmJDQ29BQ3BhQTA4dDdSSUt4MEFjZy1feENybmRYT3JHZl9Ca04wazgtdlNsZFZJaVlUT0NGWmFTZkFILVVlM21hUFh1MzA?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T21:35:46+00:00", "published_display": "15 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Inc (ELV) Q2 2026 Earnings Call Highlights: Strong EPS Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/elevance-health-inc-elv-q2-210029819.html", "source_name": "GuruFocus.com", "published_at": "2026-07-15T21:00:29+00:00", "published_display": "15 Jul 2026 21:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Inc Stock (ELV) Closed Down by 8.71% on Jul 15: Key Drivers Unveiled", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNSmFVN2FQM2JKUEJ2YU1ieGE2TWhFUWlyRlRoejhoQTJqR1JqaWZmMUMtNFRiMWRBa3d2VWlfNHh3YVFtU1hCNDFwa3R6Ym5XTUpXYTVFTGozT2dVUGRSN2lnNzcyTDhQcEdMLVg1dGJhbHZKWDNQcDVUTmdqRXI1bGJwMC1lVUxIVkE?oc=5", "source_name": "TradingKey", "published_at": "2026-07-15T20:15:12+00:00", "published_display": "15 Jul 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Q3 2025 earnings summary", "summary": "Elevance Health reported strong Q3 2025 results with operating revenue up 12% year-over-year to $50.1 billion and diluted EPS of $5.32. Despite a slight decline in medical membership, the company returned $3.3 billion to shareholders year-to-date and reaffirmed its full-year 2025", "url": "https://quartr.com/events/elevance-health-inc-elv-q3-2025_3e3sTSM6", "source_name": "Quartr", "published_at": "2026-07-15T21:08:32", "published_display": "15 Jul 2026 21:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilon health stock hits 52-week high at 126.0 USD", "summary": "Agilon Health Inc. stock reached a 52-week high of $125.71, currently trading at $125.66, reflecting a year-to-date return of 612% and a one-year gain of 123%. Despite trading with high price volatility, InvestingPro analysis suggests the stock remains undervalued relative to its", "url": "https://www.investing.com/news/company-news/agilon-health-stock-hits-52week-high-at-1260-usd-93CH-4794115", "source_name": "Investing.com", "published_at": "2026-07-15T19:45:45", "published_display": "15 Jul 2026 19:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries", "summary": "", "url": "https://finance.yahoo.com/m/c9703993-a905-371f-8a14-ce6a30a8324c/elevance-beat-earnings.html", "source_name": "Barrons.com", "published_at": "2026-07-15T17:39:00+00:00", "published_display": "15 Jul 2026 17:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Inc. stock underperforms Wednesday when compared to competitors", "summary": "Shares of Elevance Health Inc. (ELV) fell by 8.54% on Wednesday, closing at $390.33, despite a positive trading session for the broader stock market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains, but Elevance Health's stock performance snapped a two-day w", "url": "https://www.marketwatch.com/data-news/elevance-health-inc-stock-underperforms-wednesday-when-compared-to-competitors-55f3c403-1b43af5fa4b6", "source_name": "MarketWatch", "published_at": "2026-07-15T16:30:00", "published_display": "15 Jul 2026 16:30", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Elevance Health beats Q2 2026 estimates but shares fall", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQX1AtS3BlcFJXUmNWWDNoVlVfX3NjSV9razJMUUVONkxnU01FYXR5ZTRaTjUyaHdqN3Z6Q2YwYTNhZ2d2MzF4UDh4ZzFwakdjRVpzYUczVkdQalYxbDEyRXc4NWpWLU9zMndyRHJDSTh5UnFHWS00ZnhoZXN3R0FlUFV4dmwta3pJZGV4Z2hBUkItR3BHbTNPUXZ6SEl5RXpsWWRXRDU0V1pLVUxmNDZ0Q3J0RzV6V1Itc3dLMVVsRV95VnNQSkN6ZjhPbTBvRjgtaUE?oc=5", "source_name": "Investing.com", "published_at": "2026-07-15T15:08:12+00:00", "published_display": "15 Jul 2026 15:08", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (NYSE: ELV) logs $1,463M Q2 2026 shareholder profit", "summary": "Elevance Health reported Q2 2026 revenues of $50,474 million, up slightly from the previous year, but shareholder net income declined to $1,463 million due to expenses growing faster than revenue. Diluted EPS for the quarter was $6.71, down from $7.72. The company also announced ", "url": "https://www.stocktitan.net/sec-filings/ELV/10-q-elevance-health-inc-quarterly-earnings-report-e0ff6f70cd77.html", "source_name": "Stock Titan", "published_at": "2026-07-15T15:28:17", "published_display": "15 Jul 2026 15:28", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health, Inc. Q2 2026: Revenue $50.47B, EPS $6.71\u2014 10-Q Summary", "summary": "Elevance Health, Inc. reported its second-quarter 2026 results, showing total revenue of $50.47 billion, a modest increase year-over-year, while diluted EPS declined to $6.71. The company experienced an increase in operating revenue due to premium rate adjustments and growth in C", "url": "https://www.tradingview.com/news/tradingview:660a1c2fbc0e1:0-elevance-health-inc-q2-2026-revenue-50-47b-eps-6-71-10-q-summary/", "source_name": "TradingView", "published_at": "2026-07-15T15:08:22", "published_display": "15 Jul 2026 15:08", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Reports Strong Q2 Earnings, Raises FY 2026 Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOby1pSFNVdGdXRlducGxIWVQxNndpRkdkd0w0YktfSjJWM3J1R3NxblpJa3lqQ0VSbklMY3lUUVJRTlY0NHFfS2dvMWVydUY3THk2Ry1Cd1AwSTA5RVZXajNtbjNDVnlBOGlzdlB1MF9rUV92WTlTeUwzWHVxLVE4OFNQRTV5YnRjX012eGlqMVlwZmdFX2lNWko4Rm8zSmVlY2xCX2hNTEVYb1ozZ1E?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T13:43:53+00:00", "published_display": "15 Jul 2026 13:43", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Is Focused on Improving Margins While Facing Near-Term Challenges", "summary": "Elevance Health, a major licensee of the Blue Cross Blue Shield brand in 14 states, is working to improve its margins despite immediate challenges. The company holds a strong market position, insuring about one-third of the population in its licensed states, which aids in reimbur", "url": "https://www.morningstar.com/company-reports/1488103-elevance-is-focused-on-improving-margins-while-facing-near-term-challenges", "source_name": "Morningstar", "published_at": "2026-07-15T14:37:45", "published_display": "15 Jul 2026 14:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health insurance stocks slide after Elevance highlights margin pressures (ELV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOU01kMjl4SVBkYUcyYkFaTkVidDhTTV9JdEtURFB0d20zNzJOZE5MS3NOV0JTZmxYVTVCekE2cTBybGE5QUxJbXZVSUpOVmlVUzZBN0dPRFk0LUF1Q3NHcldjVm00RGNwTnpOU09ZYUM4Tmo2X2xMQ09VbW53VWpqdFdYMWRCOFRJNmZmdVJuUXVya3RqOTJ3T1BsQlhMUU44?oc=5", "source_name": "Market source", "published_at": "2026-07-15T13:36:40+00:00", "published_display": "15 Jul 2026 13:36", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Compared to Estimates, Elevance Health (ELV) Q2 Earnings: A Look at Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOaU15VTN4cEhaMmhpa1lzOEZBeVR2QmNrc2xZNkZ2Rk5oNHpuZVByQThCWndfS3ZSY21hWjdKOUtvaVA0MXZfT3lzdTdPZGpjMDhPcFB5WFVZZU9Bd1VjT2hUeFBXLUc5SGpzMkt0dm5IWnROSVZ0OXVpOXVqYk5obUNKdG5SQkdOd0tURUxOU1BNdE5xWkFNeHRqdGEwY2J5?oc=5", "source_name": "Market source", "published_at": "2026-07-15T13:30:03+00:00", "published_display": "15 Jul 2026 13:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Elevance Health Stock Sinking Wednesday? - Elevance Health (NYSE:ELV)", "summary": "Elevance Health's stock is sinking despite beating Q2 earnings estimates and raising full-year guidance. Investors were reportedly underwhelmed as the guidance increase was smaller than the quarterly earnings beat, leading to a broader selloff among managed-care insurers. Elevate", "url": "https://www.benzinga.com/markets/earnings/26/07/60471497/elevance-healths-small-outlook-boost-disappoints-stock-sinks", "source_name": "Benzinga", "published_at": "2026-07-15T14:22:44", "published_display": "15 Jul 2026 14:22", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVS Health Risk Factors: Key Regulatory, PBM, Insurance, and Pharmacy Risks", "summary": "CVS Health faces significant risks across its diversified healthcare operations, including regulatory pressures on PBMs and pharmacies, medical cost volatility in its insurance segment (Aetna), and execution challenges from integration and acquisitions. The company's earnings sta", "url": "https://insurancenewsnet.com/oarticle/cvs-health-risk-factors-key-regulatory-pbm-insurance-and-pharmacy-risks", "source_name": "InsuranceNewsNet", "published_at": "2026-07-15T14:07:41", "published_display": "15 Jul 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPOVdtZ1lIREhiTjdkM0otV2NERlVELU9ENE0wd0hRN2U4dDVKT3VPQmJIWVowcTFOZ0lnUEczbXNua2Rab1ZKQ3dlUVBXZmY1Q2VMS0dEMkVLdnZycnBMY1plNXh0VXNiQmthM3lZSTJDSko3Q1A1RmUzOGxqRjlKOGkyRk1jYldpeWJKTk9mYw?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-07-15T12:56:00+00:00", "published_display": "15 Jul 2026 12:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Reports Strong Q2 Earnings, Raises Full-Ye", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOR1VObktGS1F4U3RYRjFVc3BuaW5pXzlxX3ZHTnlraC1XdjRYYmpNeGNEZ0c4ZnktYWN4UHZOemRTQXRmSHM4dHR6UXJ6X19tSDkyQ2ZqNTd0QjBRNHpHVnd6QjRJMWJ5TTNzWnAxcjVjb21PNDRsNFUxVW5ZcUt4OTRpaHVnbDA0TUpMUzFibXY4cEVmbmV1eXpBNnpaYk80RW1KaERCdlRGZnl5OXVDUk90VC1XbDJXeDRxaDVSTQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T12:43:38+00:00", "published_display": "15 Jul 2026 12:43", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Faces Significant Pre-Market Decline of 12", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNWGtKVGFuZkk0M215ZUFWN3ZwdEdRaWd2Z1VyS1VKbkZxb0tzWFJzU2h5S2xZbFhjSlRMR2tDLS13NDQ4UVd5eGFfVG5vcElTdlNuV21Vb1JZM1lIaV84LTY3dmVDc1ZkYWhWaHUzYXBXV05fVVU2dmlMVjV0dV9lWE9BNVJORkVaaHZwS3RiOTRpYzYxTFM5dDVVODZMWmp5NEww?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T12:35:36+00:00", "published_display": "15 Jul 2026 12:35", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health beats second-quarter forecasts but shares slide on margin pressure (ELV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQTlNmdHl3b3lBdnJGTjZYZjYzdmZCTXNMOWV5bHloQXREWHhIMXlhZGZycWg3YzktUnRFa3U5N2tPX3RYUkhFNjNURnJnLXE5RzlYX2dRZ0hpOUROelRhWEhNaV85ak5LWG1vSnN6cFZNZ0tPb2hrX25qRUI4aFByR1dta01WcF83anQ1UkNxUC1DQVVfT2oxNVFGX20ydw?oc=5", "source_name": "Market source", "published_at": "2026-07-15T12:29:15+00:00", "published_display": "15 Jul 2026 12:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix wins coverage for Alzheimer\u2019s test (QTRX:NASDAQ)", "summary": "Quanterix Corporation saw a ~3% increase in premarket trading after announcing that its Alzheimer\u2019s test, LucentAD Complete, will be covered by Elevance Health\u2019s Anthem Blue Cross and Blue Shield health plans starting this month. This coverage is expected to expand access to the ", "url": "https://seekingalpha.com/news/4614001-quanterix-wins-coverage-alzheimers-test", "source_name": "Seeking Alpha", "published_at": "2026-07-15T12:40:16", "published_display": "15 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQNl82Q2tILXI5MXk0MTJyN29FY2Y3eW10WU4zUTdEdzdlNW90SWJvQlljTWduQXJhdlQ3T1JDM2FjMTU0VDhrSzE5NkpOcmpxT2VUdmpUUEhrVDZTVkxqZTFmZFpLOXlwZG95eU80THlOM21LaVNFN2d4QzlGVHFWYUx6LXIzQ1pM?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T11:10:01+00:00", "published_display": "15 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "S&P 500 Futures Climb in Premarket Trading; Pentair, Elevance Health Lag", "summary": "S&P 500 futures showed gains in premarket trading. Among individual stocks, PayPal Holdings Inc. (PYPL) saw a significant increase of 20.3%, and Elanco Animal Health Inc. (ELAN) rose by 7.6% ahead of the market open. The article highlights these early movements in the market.", "url": "https://www.barrons.com/articles/s-p-500-futures-climb-in-premarket-trading-pentair-elevance-health-lag-0b20f54b", "source_name": "Barron's", "published_at": "2026-07-15T11:30:03", "published_display": "15 Jul 2026 11:30", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ELEVANCE HEALTH ($ELV) Releases Q2 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxONmFLbTI5YnJiNlRRZUpXeXg2VkxPV0FtQ0djcHVkRmlENEhocVM2b2k3TlVNOEhhQWgxLUJUMWZWclhDNl9Wd1poZ1FxVzFNcWxrcE4xWVhkbk1DRUt1ZGQ0QnRMc0xCaGNuZUQ5bW5Sb21RUmphMFVnenBtTzZnd2tFN2JqTzBPVkxkTmFvdzM?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-15T10:30:00+00:00", "published_display": "15 Jul 2026 10:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Releases Q2 2026 Financial Results", "summary": "Elevance Health Inc. (ANTM) announced its Q2 2026 financial results, reporting adjusted diluted EPS of $7.45 and revenue of $49.83 billion, an increase of 0.8% year-over-year. The company's net income reached $1.62 billion, with medical membership totaling 44,949,000. For the nex", "url": "https://news.alphastreet.com/elevance-health-releases-q2-2026-financial-results/", "source_name": "AlphaStreet", "published_at": "2026-07-15T11:04:05", "published_display": "15 Jul 2026 11:04", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (NYSE:ELV) Reports Bullish Q2 CY2026", "summary": "Elevance Health (NYSE:ELV) exceeded Wall Street's revenue and adjusted EPS expectations in Q2 CY2026, with sales up 2.1% year-on-year to $50.47 billion and non-GAAP profit of $7.45 per share. Despite a decrease in customer numbers, the company's operating margin significantly imp", "url": "https://www.tradingview.com/news/stockstory:593c2d1ee094b:0-elevance-health-nyse-elv-reports-bullish-q2-cy2026/", "source_name": "TradingView", "published_at": "2026-07-15T10:38:04", "published_display": "15 Jul 2026 10:38", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Flash (ELV) Elevance Health, Inc. Posts Q2 Adjusted EPS $7.45 per Share", "summary": "Elevance Health, Inc. (ELV) reported an adjusted EPS of $7.45 per share for Q2 2026. The company also announced Q2 revenue of $49.83 billion, surpassing the FactSet estimated $48.84 billion, and raised its full-year adjusted EPS outlook. Following these results, several analysts ", "url": "https://www.marketscreener.com/news/earnings-flash-elv-elevance-health-inc-posts-q2-adjusted-eps-7-45-per-share-ce7f5eddd088f025", "source_name": "marketscreener.com", "published_at": "2026-07-15T10:38:04", "published_display": "15 Jul 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance raises annual profit forecast on better medical cost management", "summary": "Elevance Health has increased its annual profit forecast after exceeding second-quarter earnings expectations. This positive outlook is attributed to the company's effective medical cost management strategies. The insurer also reported a better-than-expected medical loss ratio, i", "url": "https://www.reuters.com/legal/litigation/elevance-raises-annual-profit-forecast-better-medical-cost-management-2026-07-15/", "source_name": "Reuters", "published_at": "2026-07-15T10:38:03", "published_display": "15 Jul 2026 10:38", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Q2 Earnings Exceed Expectations", "summary": "Elevance Health reported strong Q2 2026 earnings, surpassing expectations with a non-GAAP EPS of $7.45 and revenue of $49.83 billion. The company also upgraded its full-year 2026 diluted EPS and operating cash flow guidance, indicating a positive outlook. Analysts largely maintai", "url": "https://intellectia.ai/news/stock/elevance-health-q2-earnings-exceed-expectations", "source_name": "Intellectia AI", "published_at": "2026-07-15T10:09:50", "published_display": "15 Jul 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health reports Q2 2026: Revenue $49.8B, Adj. diluted EPS $7.45, raises FY guidance", "summary": "Elevance Health reported strong Q2 2026 results, with operating revenue reaching $49.8 billion and adjusted diluted EPS of $7.45. The company has raised its full-year 2026 guidance, projecting at least $20.10 diluted EPS and $27.00 adjusted diluted EPS, citing positive benefit ex", "url": "https://www.tradingview.com/news/tradingview:bf1d86c9a118e:0-elevance-health-reports-q2-2026-revenue-49-8b-adj-diluted-eps-7-45-raises-fy-guidance/", "source_name": "TradingView", "published_at": "2026-07-15T10:09:00", "published_display": "15 Jul 2026 10:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Raises Guidance on Lower-Than-Expected Medical Costs", "summary": "Elevance Health Inc. has raised its annual profit guidance for the second consecutive quarter, signaling a positive trend for the health insurance industry amidst recent federal policy adjustments. The company now forecasts full-year adjusted earnings of at least $27 per share, a", "url": "https://www.bloomberg.com/news/articles/2026-07-15/elevance-raises-guidance-on-lower-than-expected-medical-costs", "source_name": "Bloomberg.com", "published_at": "2026-07-15T10:08:50", "published_display": "15 Jul 2026 10:08", "sentiment": "positive", "sentiment_pct": 71, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (NYSE: ELV) lifts 2026 EPS guidance on Q2 results", "summary": "Elevance Health reported strong Q2 2026 results, exceeding expectations with operating revenue of $49.8 billion. The company raised its full-year 2026 diluted EPS guidance to at least $20.10 and adjusted diluted EPS guidance to at least $27.00, along with increasing operating cas", "url": "https://www.stocktitan.net/sec-filings/ELV/8-k-elevance-health-inc-reports-material-event-03ce1655158e.html", "source_name": "Stock Titan", "published_at": "2026-07-15T10:08:50", "published_display": "15 Jul 2026 10:08", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health beats estimates but shares fall on margin concerns", "summary": "Elevance Health Inc. reported Q2 results that exceeded analyst expectations for adjusted EPS and revenue. However, shares fell more than 9% premarket due to concerns over declining operating margins, which dropped to 3.5% from 4.9% in the prior year quarter. Despite this, the com", "url": "https://m.investing.com/news/earnings/elevance-health-beats-estimates-but-shares-fall-on-margin-concerns-4792719?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-15T10:08:22", "published_display": "15 Jul 2026 10:08", "sentiment": "negative", "sentiment_pct": 35, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Reports $49.8B Revenue as Medical Costs Rise", "summary": "Elevance Health reported Q2 2026 operating revenue of $49.8 billion, a 0.8% increase from the prior year, exceeding expectations. The company raised its full-year adjusted EPS guidance to at least $27.00, attributing it to strong operating results and strategic investments in med", "url": "https://www.stocktitan.net/news/ELV/elevance-health-reports-second-quarter-2026-results-raises-full-year-upnt93snu10k.html", "source_name": "Stock Titan", "published_at": "2026-07-15T09:59:59", "published_display": "15 Jul 2026 09:59", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health system finances feeling the squeeze from federal policy", "summary": "The financial health of hospital systems is under stress due to federal policy, with HCA Healthcare's Affordable Care Act losses highlighting a broader industry strain. Patients facing increased healthcare costs are opting for different plans or leaving the insurance market entir", "url": "https://www.modernhealthcare.com/providers/mh-hca-healthcare-aca-exchange-hospitals/", "source_name": "Modern Healthcare", "published_at": "2026-07-15T09:40:46", "published_display": "15 Jul 2026 09:40", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Expanded Coverage for Guardant\u2019s Shield Test Will Impact UnitedHealth Group (UNH) Investors", "summary": "UnitedHealth Group (UNH) has expanded coverage for Guardant Health Inc.'s Shield blood test for colorectal cancer screening to roughly 40 million eligible members. This move aligns with UNH's focus on preventive care but is unlikely to immediately outweigh issues like Medicare Ad", "url": "https://simplywall.st/stocks/us/healthcare/nyse-unh/unitedhealth-group/news/how-expanded-coverage-for-guardants-shield-test-will-impact", "source_name": "Simply Wall Street", "published_at": "2026-07-15T05:09:22", "published_display": "15 Jul 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies Adjusts Price Target on Elevance Health to $393 From $391, Maintains Buy Rating", "summary": "Jefferies has adjusted its price target for Elevance Health (ELV) to $393, an increase from its previous target of $391. The firm has also reiterated its Buy rating on the healthcare company's stock. This modest price target revision indicates continued confidence in Elevance Hea", "url": "https://www.moomoo.com/news/post/72924271/jefferies-adjusts-price-target-on-elevance-health-to-393-from", "source_name": "Moomoo", "published_at": "2026-07-14T15:08:21", "published_display": "14 Jul 2026 15:08", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will the Market Recognize the True Potential of Elevance Health (ELV)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeHN6eC1VaEl2OEtMdmFld2Q4UnhrWVFVUnJ5V0VjNUtNZ3A3SGpaMW42Z0ctYnVUVEhFemVtU3lTWDR4TVJXZ2YzTzVacEw5aXNRY19XTW5sWXpQcm5XbTJIQ2JJRWVPT1NRSnU2Zk5pSGI5bHJWZjZVZzc0Ql9vLUtNOUxkWlJydUZ2bU40LUY3cWtNTHFhcF9WSU9vMUtYWXNGMDhkWFQ?oc=5", "source_name": "Market source", "published_at": "2026-07-14T13:55:55+00:00", "published_display": "14 Jul 2026 13:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Stock And 2 Defensive Picks For Higher Interest Rates", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T10:19:18+00:00", "published_display": "14 Jul 2026 10:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "6 Best Health Insurance Stocks for 2026 and How to Invest", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNN3A4NnZ3UnRPMFJpSEtJdGcyM1VpSDFtT2FMM09mQ01PckM2SzJ6elRHT1BPYl9IUGl2S2NXM21HSWdPa0tacUU2LTBpY3Btc3ZuNmNQRDhTaFlJQzVVcGVMX2hIWnJCZTlWT0FXdUIzcjd5M2dvbjFqTHRKWU01TkRTb0FsSEVmR3lhSl81NG9uVHVlS1UzeTV6Q25KMlVoNkt3al9fcElpcFNiTllUVQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-13T15:49:00+00:00", "published_display": "13 Jul 2026 15:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Stock Looks Reasonable On Earnings But Stretched After 25% Gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-12T22:32:00+00:00", "published_display": "12 Jul 2026 22:32", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health stock reflects the insurer's scale and diversified health benefits business", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNV0ZNMUdwYzhvSWRucTd4UU9JNndRdWVzbHlraVBGU0VsaU11Y2NvUjBlendPRG5mWm84b0swQXhTTGRXY1pBVDZUejJuNWk5X0hubkVESXhSd1R0b1diM245aUkyM1V2dUUyYmZTNzBueEV3Vko1Y200TG1xcEU1LURRUUNRaXFzVGVaVzMyX3lDeDhWSjdRVTZRZV9nMkszSzkxZ3k2VWFEYUlZb3k4Vk9qVTU1dnUxNGhwWXVlR05UM05WQUpRS1pvb0c?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-12T07:45:29+00:00", "published_display": "12 Jul 2026 07:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Elevance Health (ELV) Oncology Test Deal And Factor Index Reclassification", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T19:05:06+00:00", "published_display": "09 Jul 2026 19:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Could Be 20% Undervalued As Health OS Expansion Draws Focus", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T22:36:13+00:00", "published_display": "05 Jul 2026 22:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Sues CMS Over Medicare Ratings And Bonus Payment Rules", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Plus Therapeutics gets national health coverage for CNS cancer test", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPQ1p1TTZyc1lEcFd1eHRRZW1fUnlpX1B5U1gxeFltenVDc294MEtIczB0cWdXbGt5UWR6am5Rd2xSTi1mMHVSYkVLM1RHaGF3cXYwemR0czZyVkM5TC1TR0d2RzZpbUstZTdiT3RHQ3BuRV9GQ2JMYkVUN0NxZXRZQ3ZwT3BQbjhjNGdseVNmNGJQQmJZMG9kdTgwTDVYdk9PRG5BUjc4OWtCal9FWDh1VXFpcHQ0NjZTdmQ1eWFKdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health puts $640M into affordable housing, aiding 40,000 units", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPRlFyRUpscENnamRSLTdlcWMybm5Hd2psX0hwdUdvOGNnUDhhOGJfUTFMR3lta0pORXdjcW5pTElqclZLdlFtT3dqZGk5VjJIdGNZWkJQdDQ3Mk0taC00T1pqbnp3MVd5RWN3UklmQnlJZHlObE9GLXVMelBmQ2dSbkxCUnl0Z1FjVzRnNUJySVoxakotMVdLZ25LczFHaHM0bk5Ba2NPRGh0R291LVlyLUdkYWxqSHM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (NYSE: ELV) reiterates 2026 EPS and benefit ratio outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQUHhFYnl1TlBmNVVXY0pMd0pVN1U1NE16WWd1OGROdXJvcTMwajc0TDViU0xnZ3I4QkNkR3VINzRBTTdwSUtVUmtmTlVyampwbWctemVzM2hWbWNwVXpodjZiQlIyQ09DUWdGVEVqeGtmcVhibEFobEwtQmNqaW1sWWhUVDB3cjJRVy11alFJZV9RX0NEVTViVmIwWlB5S0x3TFIzSVRydWxnSkE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade) (NYSE:ELV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZXdyWFNCeEZnMWFmMi0taV8yVjZxMnJaMnVEZENMZGJ1X0ZQdmluWGhob0lIcWlNWmlNR2JSeENwampmaGlrUVBfS0FDOEtUWkhIWGxxLXdfTjl4NEZ5WVV2aTRlMmNneG9aT3ZYT0lZYS1vemFaTlduaUZCYlFzVHpwcXZja042SjhhdS1ra3g5dXUxdjFmbE9KSGdHejFQdGhjYnZvRkwtQkVOWnVyWG1Bdw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bullish Elevance Health Insiders Loaded Up On US$3.68m Of Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNLXRnZHZubzdXdUx6a2dCTGJ5QWhMcG9RVE80d3pOX3hmV2VaMmYtSXF1SklwUVJndnZwSS1mR3lucDdxaGtLRHRPQ0RTc2JhQXFMV1Fibm9MN2g3eUpFSUxsX1NrLWw1QW9fZTlMaFpETzRkQy1CckhLbWJ1UHY5SlJNY2JHQVZlN1BHeUdjYTVXUVJsS0hObC02UlFWdUVTZ24tc0RUYw?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Free phones and 24/7 care: Elevance Health tackles the digital health divide", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOMVRmczhSbjBtU2RnbE9WWEhrd2p3OFJ0NXotdms2eVdDMzY4WHB4Z0ZzdTd6MXRveHowSFJtSmp1QjVNcWNSS2N2WjhEUVRkRk5NY0NSY1RvcW83Z1pLejB1MjNYc0RaSkgyWW9RYUpOR1Vaa3ZSMXRydHdYQVlZRjZIUWEtMHpybW1wdEg3X3hDY0lZVzZPdXVUejREME5sakFiUlQ5U3hBT0xiSzNMVW94Rmt4a2luRXZKNQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UBS Reaffirms Buy on Elevance Health (ELV) Amid Stronger Industry Trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQUm9jeU1reTdiNHc4QkhSR0YwMTJfc2xiLXprUmx6VHVDa0o1RUNNaTl5a2NRUnR6Z2lyOXlmeTZVX3Vhb0hFZm1sRTFyWktnNXFBT09KSnlxalhuYUlEQ0hXQURyaFA3b2Z3MUMwV3lnU2pjamZySERCWFM3ZXBkR2ZjQWprQ3ljQkV5d2laNzJMWUg2U09NNlMyX20tbE5HN0JkZA?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Stock Analysis: Guidance Raised to $27, Street High at $498, TIKR Target at $534", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQNHhlSk1RUTJKU3dlUmd6Zi0xdVZCeG90M1BXSDZPVDZFZlhybXh4SlZzNEN0b2hIOWU5dmVLSTNnNVEtU05sRDM2d2ItUEhqMkdFODJleVlkeTZzMW5lM1FrVnFGc0h2S3ZEMXVqVVdSRVgxSU1SRzhNUHNNWFJ4R01NUWpkT0F1NjhiUUVLTjFKSEdCdkJqMkhSX3N1aU8tb3V0QlBHVjJianI4eVViZVVZMTBWQ0U?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Stock Rises on Q1 Beat and Guidance Raise: What\u2019s Next?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOdHhuZzJFT24waWZBM1E1cWp3eGxzUFI1Q2NWR3I3NGdDclJHU2lsUUh6MWpFSFp3RlA0cFdDc21RMXp1MkdLX1M2WURDa3JqR2xUT0xuUVZTMWk4bUVVU2xtWl83Z2N3WUdVc0ZQVmMxR053MlFLN0ZNSTBhMGpPV2x6UXZoWkRXeV85dG9BYzVfa3N0NTJWTU5R?oc=5", "source_name": "TIKR.com", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Margin Compression To 2.6% Tests Bullish Efficiency Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/elevance-health-elv-beats-q2-032418395.html", "source_name": "Simply Wall St.", "published_at": "2026-07-16T03:24:18+00:00", "published_display": "16 Jul 2026 03:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Q2 2026 Earnings Call Transcript", "summary": "", "url": "https://finance.yahoo.com/m/8f94590a-3346-3440-9309-ff8df1743e88/elevance-health-%28elv%29-q2-2026.html", "source_name": "Motley Fool", "published_at": "2026-07-16T00:32:19+00:00", "published_display": "16 Jul 2026 00:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analyst Report: Elevance Health, Inc.", "summary": "", "url": "https://finance.yahoo.com/m/76a9d924-2686-32d9-b300-fad96b24e8e7/analyst-report%3A-elevance.html", "source_name": "Morningstar Research", "published_at": "2026-07-16T00:12:27+00:00", "published_display": "16 Jul 2026 00:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Q2 2025 earnings summary", "summary": "Elevance Health reported Q2 2025 operating revenue of $49.4 billion, a 14.3% year-over-year increase, driven by higher premium yields and Medicare Advantage growth, but net income decreased by 24.2% to $1.74 billion due to elevated medical costs. The company revised its full-year", "url": "https://quartr.com/events/elevance-health-inc-elv-q2-2025_3e3sT0pc", "source_name": "Quartr", "published_at": "2026-07-16T00:08:00", "published_display": "16 Jul 2026 00:08", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Nears Earnings With Long Term Confidence Testing A Fair Value View", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T21:35:58+00:00", "published_display": "15 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Inc (ELV) Stock Down 8.5% -- Now Undervalued? GF Score: 88/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZDFqNDY4aFhqTnRSM3AtLWZuMTA1S2JTUllMWDlnME80djRUZGMtSWlNTjFNcGpvbDg0SW9Fci1jTDlIN015Q3hFWFZSODNqOVE2YWQ4N1d2UzhWaEhCSl9xVlpNYmJDQ29BQ3BhQTA4dDdSSUt4MEFjZy1feENybmRYT3JHZl9Ca04wazgtdlNsZFZJaVlUT0NGWmFTZkFILVVlM21hUFh1MzA?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T21:35:46+00:00", "published_display": "15 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Inc (ELV) Q2 2026 Earnings Call Highlights: Strong EPS Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/elevance-health-inc-elv-q2-210029819.html", "source_name": "GuruFocus.com", "published_at": "2026-07-15T21:00:29+00:00", "published_display": "15 Jul 2026 21:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Inc Stock (ELV) Closed Down by 8.71% on Jul 15: Key Drivers Unveiled", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNSmFVN2FQM2JKUEJ2YU1ieGE2TWhFUWlyRlRoejhoQTJqR1JqaWZmMUMtNFRiMWRBa3d2VWlfNHh3YVFtU1hCNDFwa3R6Ym5XTUpXYTVFTGozT2dVUGRSN2lnNzcyTDhQcEdMLVg1dGJhbHZKWDNQcDVUTmdqRXI1bGJwMC1lVUxIVkE?oc=5", "source_name": "TradingKey", "published_at": "2026-07-15T20:15:12+00:00", "published_display": "15 Jul 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Q3 2025 earnings summary", "summary": "Elevance Health reported strong Q3 2025 results with operating revenue up 12% year-over-year to $50.1 billion and diluted EPS of $5.32. Despite a slight decline in medical membership, the company returned $3.3 billion to shareholders year-to-date and reaffirmed its full-year 2025", "url": "https://quartr.com/events/elevance-health-inc-elv-q3-2025_3e3sTSM6", "source_name": "Quartr", "published_at": "2026-07-15T21:08:32", "published_display": "15 Jul 2026 21:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilon health stock hits 52-week high at 126.0 USD", "summary": "Agilon Health Inc. stock reached a 52-week high of $125.71, currently trading at $125.66, reflecting a year-to-date return of 612% and a one-year gain of 123%. Despite trading with high price volatility, InvestingPro analysis suggests the stock remains undervalued relative to its", "url": "https://www.investing.com/news/company-news/agilon-health-stock-hits-52week-high-at-1260-usd-93CH-4794115", "source_name": "Investing.com", "published_at": "2026-07-15T19:45:45", "published_display": "15 Jul 2026 19:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries", "summary": "", "url": "https://finance.yahoo.com/m/c9703993-a905-371f-8a14-ce6a30a8324c/elevance-beat-earnings.html", "source_name": "Barrons.com", "published_at": "2026-07-15T17:39:00+00:00", "published_display": "15 Jul 2026 17:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Inc. stock underperforms Wednesday when compared to competitors", "summary": "Shares of Elevance Health Inc. (ELV) fell by 8.54% on Wednesday, closing at $390.33, despite a positive trading session for the broader stock market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains, but Elevance Health's stock performance snapped a two-day w", "url": "https://www.marketwatch.com/data-news/elevance-health-inc-stock-underperforms-wednesday-when-compared-to-competitors-55f3c403-1b43af5fa4b6", "source_name": "MarketWatch", "published_at": "2026-07-15T16:30:00", "published_display": "15 Jul 2026 16:30", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Elevance Health beats Q2 2026 estimates but shares fall", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQX1AtS3BlcFJXUmNWWDNoVlVfX3NjSV9razJMUUVONkxnU01FYXR5ZTRaTjUyaHdqN3Z6Q2YwYTNhZ2d2MzF4UDh4ZzFwakdjRVpzYUczVkdQalYxbDEyRXc4NWpWLU9zMndyRHJDSTh5UnFHWS00ZnhoZXN3R0FlUFV4dmwta3pJZGV4Z2hBUkItR3BHbTNPUXZ6SEl5RXpsWWRXRDU0V1pLVUxmNDZ0Q3J0RzV6V1Itc3dLMVVsRV95VnNQSkN6ZjhPbTBvRjgtaUE?oc=5", "source_name": "Investing.com", "published_at": "2026-07-15T15:08:12+00:00", "published_display": "15 Jul 2026 15:08", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (NYSE: ELV) logs $1,463M Q2 2026 shareholder profit", "summary": "Elevance Health reported Q2 2026 revenues of $50,474 million, up slightly from the previous year, but shareholder net income declined to $1,463 million due to expenses growing faster than revenue. Diluted EPS for the quarter was $6.71, down from $7.72. The company also announced ", "url": "https://www.stocktitan.net/sec-filings/ELV/10-q-elevance-health-inc-quarterly-earnings-report-e0ff6f70cd77.html", "source_name": "Stock Titan", "published_at": "2026-07-15T15:28:17", "published_display": "15 Jul 2026 15:28", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health, Inc. Q2 2026: Revenue $50.47B, EPS $6.71\u2014 10-Q Summary", "summary": "Elevance Health, Inc. reported its second-quarter 2026 results, showing total revenue of $50.47 billion, a modest increase year-over-year, while diluted EPS declined to $6.71. The company experienced an increase in operating revenue due to premium rate adjustments and growth in C", "url": "https://www.tradingview.com/news/tradingview:660a1c2fbc0e1:0-elevance-health-inc-q2-2026-revenue-50-47b-eps-6-71-10-q-summary/", "source_name": "TradingView", "published_at": "2026-07-15T15:08:22", "published_display": "15 Jul 2026 15:08", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Reports Strong Q2 Earnings, Raises FY 2026 Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOby1pSFNVdGdXRlducGxIWVQxNndpRkdkd0w0YktfSjJWM3J1R3NxblpJa3lqQ0VSbklMY3lUUVJRTlY0NHFfS2dvMWVydUY3THk2Ry1Cd1AwSTA5RVZXajNtbjNDVnlBOGlzdlB1MF9rUV92WTlTeUwzWHVxLVE4OFNQRTV5YnRjX012eGlqMVlwZmdFX2lNWko4Rm8zSmVlY2xCX2hNTEVYb1ozZ1E?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T13:43:53+00:00", "published_display": "15 Jul 2026 13:43", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Is Focused on Improving Margins While Facing Near-Term Challenges", "summary": "Elevance Health, a major licensee of the Blue Cross Blue Shield brand in 14 states, is working to improve its margins despite immediate challenges. The company holds a strong market position, insuring about one-third of the population in its licensed states, which aids in reimbur", "url": "https://www.morningstar.com/company-reports/1488103-elevance-is-focused-on-improving-margins-while-facing-near-term-challenges", "source_name": "Morningstar", "published_at": "2026-07-15T14:37:45", "published_display": "15 Jul 2026 14:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health insurance stocks slide after Elevance highlights margin pressures (ELV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOU01kMjl4SVBkYUcyYkFaTkVidDhTTV9JdEtURFB0d20zNzJOZE5MS3NOV0JTZmxYVTVCekE2cTBybGE5QUxJbXZVSUpOVmlVUzZBN0dPRFk0LUF1Q3NHcldjVm00RGNwTnpOU09ZYUM4Tmo2X2xMQ09VbW53VWpqdFdYMWRCOFRJNmZmdVJuUXVya3RqOTJ3T1BsQlhMUU44?oc=5", "source_name": "Market source", "published_at": "2026-07-15T13:36:40+00:00", "published_display": "15 Jul 2026 13:36", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Compared to Estimates, Elevance Health (ELV) Q2 Earnings: A Look at Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOaU15VTN4cEhaMmhpa1lzOEZBeVR2QmNrc2xZNkZ2Rk5oNHpuZVByQThCWndfS3ZSY21hWjdKOUtvaVA0MXZfT3lzdTdPZGpjMDhPcFB5WFVZZU9Bd1VjT2hUeFBXLUc5SGpzMkt0dm5IWnROSVZ0OXVpOXVqYk5obUNKdG5SQkdOd0tURUxOU1BNdE5xWkFNeHRqdGEwY2J5?oc=5", "source_name": "Market source", "published_at": "2026-07-15T13:30:03+00:00", "published_display": "15 Jul 2026 13:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Elevance Health Stock Sinking Wednesday? - Elevance Health (NYSE:ELV)", "summary": "Elevance Health's stock is sinking despite beating Q2 earnings estimates and raising full-year guidance. Investors were reportedly underwhelmed as the guidance increase was smaller than the quarterly earnings beat, leading to a broader selloff among managed-care insurers. Elevate", "url": "https://www.benzinga.com/markets/earnings/26/07/60471497/elevance-healths-small-outlook-boost-disappoints-stock-sinks", "source_name": "Benzinga", "published_at": "2026-07-15T14:22:44", "published_display": "15 Jul 2026 14:22", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVS Health Risk Factors: Key Regulatory, PBM, Insurance, and Pharmacy Risks", "summary": "CVS Health faces significant risks across its diversified healthcare operations, including regulatory pressures on PBMs and pharmacies, medical cost volatility in its insurance segment (Aetna), and execution challenges from integration and acquisitions. The company's earnings sta", "url": "https://insurancenewsnet.com/oarticle/cvs-health-risk-factors-key-regulatory-pbm-insurance-and-pharmacy-risks", "source_name": "InsuranceNewsNet", "published_at": "2026-07-15T14:07:41", "published_display": "15 Jul 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPOVdtZ1lIREhiTjdkM0otV2NERlVELU9ENE0wd0hRN2U4dDVKT3VPQmJIWVowcTFOZ0lnUEczbXNua2Rab1ZKQ3dlUVBXZmY1Q2VMS0dEMkVLdnZycnBMY1plNXh0VXNiQmthM3lZSTJDSko3Q1A1RmUzOGxqRjlKOGkyRk1jYldpeWJKTk9mYw?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-07-15T12:56:00+00:00", "published_display": "15 Jul 2026 12:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Reports Strong Q2 Earnings, Raises Full-Ye", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOR1VObktGS1F4U3RYRjFVc3BuaW5pXzlxX3ZHTnlraC1XdjRYYmpNeGNEZ0c4ZnktYWN4UHZOemRTQXRmSHM4dHR6UXJ6X19tSDkyQ2ZqNTd0QjBRNHpHVnd6QjRJMWJ5TTNzWnAxcjVjb21PNDRsNFUxVW5ZcUt4OTRpaHVnbDA0TUpMUzFibXY4cEVmbmV1eXpBNnpaYk80RW1KaERCdlRGZnl5OXVDUk90VC1XbDJXeDRxaDVSTQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T12:43:38+00:00", "published_display": "15 Jul 2026 12:43", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Faces Significant Pre-Market Decline of 12", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNWGtKVGFuZkk0M215ZUFWN3ZwdEdRaWd2Z1VyS1VKbkZxb0tzWFJzU2h5S2xZbFhjSlRMR2tDLS13NDQ4UVd5eGFfVG5vcElTdlNuV21Vb1JZM1lIaV84LTY3dmVDc1ZkYWhWaHUzYXBXV05fVVU2dmlMVjV0dV9lWE9BNVJORkVaaHZwS3RiOTRpYzYxTFM5dDVVODZMWmp5NEww?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T12:35:36+00:00", "published_display": "15 Jul 2026 12:35", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health beats second-quarter forecasts but shares slide on margin pressure (ELV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQTlNmdHl3b3lBdnJGTjZYZjYzdmZCTXNMOWV5bHloQXREWHhIMXlhZGZycWg3YzktUnRFa3U5N2tPX3RYUkhFNjNURnJnLXE5RzlYX2dRZ0hpOUROelRhWEhNaV85ak5LWG1vSnN6cFZNZ0tPb2hrX25qRUI4aFByR1dta01WcF83anQ1UkNxUC1DQVVfT2oxNVFGX20ydw?oc=5", "source_name": "Market source", "published_at": "2026-07-15T12:29:15+00:00", "published_display": "15 Jul 2026 12:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix wins coverage for Alzheimer\u2019s test (QTRX:NASDAQ)", "summary": "Quanterix Corporation saw a ~3% increase in premarket trading after announcing that its Alzheimer\u2019s test, LucentAD Complete, will be covered by Elevance Health\u2019s Anthem Blue Cross and Blue Shield health plans starting this month. This coverage is expected to expand access to the ", "url": "https://seekingalpha.com/news/4614001-quanterix-wins-coverage-alzheimers-test", "source_name": "Seeking Alpha", "published_at": "2026-07-15T12:40:16", "published_display": "15 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQNl82Q2tILXI5MXk0MTJyN29FY2Y3eW10WU4zUTdEdzdlNW90SWJvQlljTWduQXJhdlQ3T1JDM2FjMTU0VDhrSzE5NkpOcmpxT2VUdmpUUEhrVDZTVkxqZTFmZFpLOXlwZG95eU80THlOM21LaVNFN2d4QzlGVHFWYUx6LXIzQ1pM?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T11:10:01+00:00", "published_display": "15 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "S&P 500 Futures Climb in Premarket Trading; Pentair, Elevance Health Lag", "summary": "S&P 500 futures showed gains in premarket trading. Among individual stocks, PayPal Holdings Inc. (PYPL) saw a significant increase of 20.3%, and Elanco Animal Health Inc. (ELAN) rose by 7.6% ahead of the market open. The article highlights these early movements in the market.", "url": "https://www.barrons.com/articles/s-p-500-futures-climb-in-premarket-trading-pentair-elevance-health-lag-0b20f54b", "source_name": "Barron's", "published_at": "2026-07-15T11:30:03", "published_display": "15 Jul 2026 11:30", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ELEVANCE HEALTH ($ELV) Releases Q2 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxONmFLbTI5YnJiNlRRZUpXeXg2VkxPV0FtQ0djcHVkRmlENEhocVM2b2k3TlVNOEhhQWgxLUJUMWZWclhDNl9Wd1poZ1FxVzFNcWxrcE4xWVhkbk1DRUt1ZGQ0QnRMc0xCaGNuZUQ5bW5Sb21RUmphMFVnenBtTzZnd2tFN2JqTzBPVkxkTmFvdzM?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-15T10:30:00+00:00", "published_display": "15 Jul 2026 10:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Releases Q2 2026 Financial Results", "summary": "Elevance Health Inc. (ANTM) announced its Q2 2026 financial results, reporting adjusted diluted EPS of $7.45 and revenue of $49.83 billion, an increase of 0.8% year-over-year. The company's net income reached $1.62 billion, with medical membership totaling 44,949,000. For the nex", "url": "https://news.alphastreet.com/elevance-health-releases-q2-2026-financial-results/", "source_name": "AlphaStreet", "published_at": "2026-07-15T11:04:05", "published_display": "15 Jul 2026 11:04", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (NYSE:ELV) Reports Bullish Q2 CY2026", "summary": "Elevance Health (NYSE:ELV) exceeded Wall Street's revenue and adjusted EPS expectations in Q2 CY2026, with sales up 2.1% year-on-year to $50.47 billion and non-GAAP profit of $7.45 per share. Despite a decrease in customer numbers, the company's operating margin significantly imp", "url": "https://www.tradingview.com/news/stockstory:593c2d1ee094b:0-elevance-health-nyse-elv-reports-bullish-q2-cy2026/", "source_name": "TradingView", "published_at": "2026-07-15T10:38:04", "published_display": "15 Jul 2026 10:38", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Flash (ELV) Elevance Health, Inc. Posts Q2 Adjusted EPS $7.45 per Share", "summary": "Elevance Health, Inc. (ELV) reported an adjusted EPS of $7.45 per share for Q2 2026. The company also announced Q2 revenue of $49.83 billion, surpassing the FactSet estimated $48.84 billion, and raised its full-year adjusted EPS outlook. Following these results, several analysts ", "url": "https://www.marketscreener.com/news/earnings-flash-elv-elevance-health-inc-posts-q2-adjusted-eps-7-45-per-share-ce7f5eddd088f025", "source_name": "marketscreener.com", "published_at": "2026-07-15T10:38:04", "published_display": "15 Jul 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance raises annual profit forecast on better medical cost management", "summary": "Elevance Health has increased its annual profit forecast after exceeding second-quarter earnings expectations. This positive outlook is attributed to the company's effective medical cost management strategies. The insurer also reported a better-than-expected medical loss ratio, i", "url": "https://www.reuters.com/legal/litigation/elevance-raises-annual-profit-forecast-better-medical-cost-management-2026-07-15/", "source_name": "Reuters", "published_at": "2026-07-15T10:38:03", "published_display": "15 Jul 2026 10:38", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Q2 Earnings Exceed Expectations", "summary": "Elevance Health reported strong Q2 2026 earnings, surpassing expectations with a non-GAAP EPS of $7.45 and revenue of $49.83 billion. The company also upgraded its full-year 2026 diluted EPS and operating cash flow guidance, indicating a positive outlook. Analysts largely maintai", "url": "https://intellectia.ai/news/stock/elevance-health-q2-earnings-exceed-expectations", "source_name": "Intellectia AI", "published_at": "2026-07-15T10:09:50", "published_display": "15 Jul 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health reports Q2 2026: Revenue $49.8B, Adj. diluted EPS $7.45, raises FY guidance", "summary": "Elevance Health reported strong Q2 2026 results, with operating revenue reaching $49.8 billion and adjusted diluted EPS of $7.45. The company has raised its full-year 2026 guidance, projecting at least $20.10 diluted EPS and $27.00 adjusted diluted EPS, citing positive benefit ex", "url": "https://www.tradingview.com/news/tradingview:bf1d86c9a118e:0-elevance-health-reports-q2-2026-revenue-49-8b-adj-diluted-eps-7-45-raises-fy-guidance/", "source_name": "TradingView", "published_at": "2026-07-15T10:09:00", "published_display": "15 Jul 2026 10:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Raises Guidance on Lower-Than-Expected Medical Costs", "summary": "Elevance Health Inc. has raised its annual profit guidance for the second consecutive quarter, signaling a positive trend for the health insurance industry amidst recent federal policy adjustments. The company now forecasts full-year adjusted earnings of at least $27 per share, a", "url": "https://www.bloomberg.com/news/articles/2026-07-15/elevance-raises-guidance-on-lower-than-expected-medical-costs", "source_name": "Bloomberg.com", "published_at": "2026-07-15T10:08:50", "published_display": "15 Jul 2026 10:08", "sentiment": "positive", "sentiment_pct": 71, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (NYSE: ELV) lifts 2026 EPS guidance on Q2 results", "summary": "Elevance Health reported strong Q2 2026 results, exceeding expectations with operating revenue of $49.8 billion. The company raised its full-year 2026 diluted EPS guidance to at least $20.10 and adjusted diluted EPS guidance to at least $27.00, along with increasing operating cas", "url": "https://www.stocktitan.net/sec-filings/ELV/8-k-elevance-health-inc-reports-material-event-03ce1655158e.html", "source_name": "Stock Titan", "published_at": "2026-07-15T10:08:50", "published_display": "15 Jul 2026 10:08", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health beats estimates but shares fall on margin concerns", "summary": "Elevance Health Inc. reported Q2 results that exceeded analyst expectations for adjusted EPS and revenue. However, shares fell more than 9% premarket due to concerns over declining operating margins, which dropped to 3.5% from 4.9% in the prior year quarter. Despite this, the com", "url": "https://m.investing.com/news/earnings/elevance-health-beats-estimates-but-shares-fall-on-margin-concerns-4792719?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-15T10:08:22", "published_display": "15 Jul 2026 10:08", "sentiment": "negative", "sentiment_pct": 35, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Reports $49.8B Revenue as Medical Costs Rise", "summary": "Elevance Health reported Q2 2026 operating revenue of $49.8 billion, a 0.8% increase from the prior year, exceeding expectations. The company raised its full-year adjusted EPS guidance to at least $27.00, attributing it to strong operating results and strategic investments in med", "url": "https://www.stocktitan.net/news/ELV/elevance-health-reports-second-quarter-2026-results-raises-full-year-upnt93snu10k.html", "source_name": "Stock Titan", "published_at": "2026-07-15T09:59:59", "published_display": "15 Jul 2026 09:59", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health system finances feeling the squeeze from federal policy", "summary": "The financial health of hospital systems is under stress due to federal policy, with HCA Healthcare's Affordable Care Act losses highlighting a broader industry strain. Patients facing increased healthcare costs are opting for different plans or leaving the insurance market entir", "url": "https://www.modernhealthcare.com/providers/mh-hca-healthcare-aca-exchange-hospitals/", "source_name": "Modern Healthcare", "published_at": "2026-07-15T09:40:46", "published_display": "15 Jul 2026 09:40", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Expanded Coverage for Guardant\u2019s Shield Test Will Impact UnitedHealth Group (UNH) Investors", "summary": "UnitedHealth Group (UNH) has expanded coverage for Guardant Health Inc.'s Shield blood test for colorectal cancer screening to roughly 40 million eligible members. This move aligns with UNH's focus on preventive care but is unlikely to immediately outweigh issues like Medicare Ad", "url": "https://simplywall.st/stocks/us/healthcare/nyse-unh/unitedhealth-group/news/how-expanded-coverage-for-guardants-shield-test-will-impact", "source_name": "Simply Wall Street", "published_at": "2026-07-15T05:09:22", "published_display": "15 Jul 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies Adjusts Price Target on Elevance Health to $393 From $391, Maintains Buy Rating", "summary": "Jefferies has adjusted its price target for Elevance Health (ELV) to $393, an increase from its previous target of $391. The firm has also reiterated its Buy rating on the healthcare company's stock. This modest price target revision indicates continued confidence in Elevance Hea", "url": "https://www.moomoo.com/news/post/72924271/jefferies-adjusts-price-target-on-elevance-health-to-393-from", "source_name": "Moomoo", "published_at": "2026-07-14T15:08:21", "published_display": "14 Jul 2026 15:08", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will the Market Recognize the True Potential of Elevance Health (ELV)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeHN6eC1VaEl2OEtMdmFld2Q4UnhrWVFVUnJ5V0VjNUtNZ3A3SGpaMW42Z0ctYnVUVEhFemVtU3lTWDR4TVJXZ2YzTzVacEw5aXNRY19XTW5sWXpQcm5XbTJIQ2JJRWVPT1NRSnU2Zk5pSGI5bHJWZjZVZzc0Ql9vLUtNOUxkWlJydUZ2bU40LUY3cWtNTHFhcF9WSU9vMUtYWXNGMDhkWFQ?oc=5", "source_name": "Market source", "published_at": "2026-07-14T13:55:55+00:00", "published_display": "14 Jul 2026 13:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Stock And 2 Defensive Picks For Higher Interest Rates", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T10:19:18+00:00", "published_display": "14 Jul 2026 10:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "6 Best Health Insurance Stocks for 2026 and How to Invest", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNN3A4NnZ3UnRPMFJpSEtJdGcyM1VpSDFtT2FMM09mQ01PckM2SzJ6elRHT1BPYl9IUGl2S2NXM21HSWdPa0tacUU2LTBpY3Btc3ZuNmNQRDhTaFlJQzVVcGVMX2hIWnJCZTlWT0FXdUIzcjd5M2dvbjFqTHRKWU01TkRTb0FsSEVmR3lhSl81NG9uVHVlS1UzeTV6Q25KMlVoNkt3al9fcElpcFNiTllUVQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-13T15:49:00+00:00", "published_display": "13 Jul 2026 15:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Stock Looks Reasonable On Earnings But Stretched After 25% Gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-12T22:32:00+00:00", "published_display": "12 Jul 2026 22:32", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health stock reflects the insurer's scale and diversified health benefits business", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNV0ZNMUdwYzhvSWRucTd4UU9JNndRdWVzbHlraVBGU0VsaU11Y2NvUjBlendPRG5mWm84b0swQXhTTGRXY1pBVDZUejJuNWk5X0hubkVESXhSd1R0b1diM245aUkyM1V2dUUyYmZTNzBueEV3Vko1Y200TG1xcEU1LURRUUNRaXFzVGVaVzMyX3lDeDhWSjdRVTZRZV9nMkszSzkxZ3k2VWFEYUlZb3k4Vk9qVTU1dnUxNGhwWXVlR05UM05WQUpRS1pvb0c?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-12T07:45:29+00:00", "published_display": "12 Jul 2026 07:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Elevance Health (ELV) Oncology Test Deal And Factor Index Reclassification", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T19:05:06+00:00", "published_display": "09 Jul 2026 19:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Could Be 20% Undervalued As Health OS Expansion Draws Focus", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T22:36:13+00:00", "published_display": "05 Jul 2026 22:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Sues CMS Over Medicare Ratings And Bonus Payment Rules", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Plus Therapeutics gets national health coverage for CNS cancer test", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPQ1p1TTZyc1lEcFd1eHRRZW1fUnlpX1B5U1gxeFltenVDc294MEtIczB0cWdXbGt5UWR6am5Rd2xSTi1mMHVSYkVLM1RHaGF3cXYwemR0czZyVkM5TC1TR0d2RzZpbUstZTdiT3RHQ3BuRV9GQ2JMYkVUN0NxZXRZQ3ZwT3BQbjhjNGdseVNmNGJQQmJZMG9kdTgwTDVYdk9PRG5BUjc4OWtCal9FWDh1VXFpcHQ0NjZTdmQ1eWFKdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health puts $640M into affordable housing, aiding 40,000 units", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPRlFyRUpscENnamRSLTdlcWMybm5Hd2psX0hwdUdvOGNnUDhhOGJfUTFMR3lta0pORXdjcW5pTElqclZLdlFtT3dqZGk5VjJIdGNZWkJQdDQ3Mk0taC00T1pqbnp3MVd5RWN3UklmQnlJZHlObE9GLXVMelBmQ2dSbkxCUnl0Z1FjVzRnNUJySVoxakotMVdLZ25LczFHaHM0bk5Ba2NPRGh0R291LVlyLUdkYWxqSHM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (NYSE: ELV) reiterates 2026 EPS and benefit ratio outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQUHhFYnl1TlBmNVVXY0pMd0pVN1U1NE16WWd1OGROdXJvcTMwajc0TDViU0xnZ3I4QkNkR3VINzRBTTdwSUtVUmtmTlVyampwbWctemVzM2hWbWNwVXpodjZiQlIyQ09DUWdGVEVqeGtmcVhibEFobEwtQmNqaW1sWWhUVDB3cjJRVy11alFJZV9RX0NEVTViVmIwWlB5S0x3TFIzSVRydWxnSkE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade) (NYSE:ELV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZXdyWFNCeEZnMWFmMi0taV8yVjZxMnJaMnVEZENMZGJ1X0ZQdmluWGhob0lIcWlNWmlNR2JSeENwampmaGlrUVBfS0FDOEtUWkhIWGxxLXdfTjl4NEZ5WVV2aTRlMmNneG9aT3ZYT0lZYS1vemFaTlduaUZCYlFzVHpwcXZja042SjhhdS1ra3g5dXUxdjFmbE9KSGdHejFQdGhjYnZvRkwtQkVOWnVyWG1Bdw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bullish Elevance Health Insiders Loaded Up On US$3.68m Of Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNLXRnZHZubzdXdUx6a2dCTGJ5QWhMcG9RVE80d3pOX3hmV2VaMmYtSXF1SklwUVJndnZwSS1mR3lucDdxaGtLRHRPQ0RTc2JhQXFMV1Fibm9MN2g3eUpFSUxsX1NrLWw1QW9fZTlMaFpETzRkQy1CckhLbWJ1UHY5SlJNY2JHQVZlN1BHeUdjYTVXUVJsS0hObC02UlFWdUVTZ24tc0RUYw?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Free phones and 24/7 care: Elevance Health tackles the digital health divide", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOMVRmczhSbjBtU2RnbE9WWEhrd2p3OFJ0NXotdms2eVdDMzY4WHB4Z0ZzdTd6MXRveHowSFJtSmp1QjVNcWNSS2N2WjhEUVRkRk5NY0NSY1RvcW83Z1pLejB1MjNYc0RaSkgyWW9RYUpOR1Vaa3ZSMXRydHdYQVlZRjZIUWEtMHpybW1wdEg3X3hDY0lZVzZPdXVUejREME5sakFiUlQ5U3hBT0xiSzNMVW94Rmt4a2luRXZKNQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UBS Reaffirms Buy on Elevance Health (ELV) Amid Stronger Industry Trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQUm9jeU1reTdiNHc4QkhSR0YwMTJfc2xiLXprUmx6VHVDa0o1RUNNaTl5a2NRUnR6Z2lyOXlmeTZVX3Vhb0hFZm1sRTFyWktnNXFBT09KSnlxalhuYUlEQ0hXQURyaFA3b2Z3MUMwV3lnU2pjamZySERCWFM3ZXBkR2ZjQWprQ3ljQkV5d2laNzJMWUg2U09NNlMyX20tbE5HN0JkZA?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Stock Analysis: Guidance Raised to $27, Street High at $498, TIKR Target at $534", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQNHhlSk1RUTJKU3dlUmd6Zi0xdVZCeG90M1BXSDZPVDZFZlhybXh4SlZzNEN0b2hIOWU5dmVLSTNnNVEtU05sRDM2d2ItUEhqMkdFODJleVlkeTZzMW5lM1FrVnFGc0h2S3ZEMXVqVVdSRVgxSU1SRzhNUHNNWFJ4R01NUWpkT0F1NjhiUUVLTjFKSEdCdkJqMkhSX3N1aU8tb3V0QlBHVjJianI4eVViZVVZMTBWQ0U?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health Stock Rises on Q1 Beat and Guidance Raise: What\u2019s Next?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOdHhuZzJFT24waWZBM1E1cWp3eGxzUFI1Q2NWR3I3NGdDclJHU2lsUUh6MWpFSFp3RlA0cFdDc21RMXp1MkdLX1M2WURDa3JqR2xUT0xuUVZTMWk4bUVVU2xtWl83Z2N3WUdVc0ZQVmMxR053MlFLN0ZNSTBhMGpPV2x6UXZoWkRXeV85dG9BYzVfa3N0NTJWTU5R?oc=5", "source_name": "TIKR.com", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elevance Health (ELV) Margin Compression To 2.6% Tests Bullish Efficiency Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 94, "total_relevant": 63, "sentiment_summary": {"positive": 22, "negative": 13, "neutral": 28, "score": 54, "total": 63, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 78, "events": [{"event": "earnings", "label": "Earnings", "weight": 19.2, "count": 33}, {"event": "general", "label": "Market update", "weight": 12.4, "count": 20}, {"event": "guidance", "label": "Guidance", "weight": 2.55, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 2.35, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 22, "negative_events": 13}, "market_context": {"has_market_context": true, "latest_close": 416.23, "latest_week": "2026-07-10", "one_week_move": -0.4, "four_week_move": 3.0, "twelve_week_move": 29.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.811902, "market_dynamics_buy_signal": false, "relative_strength": 11.574544, "fair_value_gap": 2.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.6026, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.4% over one week, +3.0% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 52, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 7}, {"label": "Stock Titan", "count": 7}, {"label": "Market source", "count": 6}, {"label": "GuruFocus", "count": 4}, {"label": "Investing.com", "count": 3}, {"label": "TradingView", "count": 3}, {"label": "Quartr", "count": 2}, {"label": "Seeking Alpha", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 63}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 33}, {"label": "Market update", "count": 20}, {"label": "Guidance", "count": 4}, {"label": "Analyst action", "count": 3}, {"label": "Deals and strategy", "count": 2}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "63", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "10", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.4% over one week, +3.0% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets"}], "updated_at": "2026-07-16T06:04:37.685279+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}